Drug – bio-affecting and body treating compositions – Antigen – epitope – or other immunospecific immunoeffector – Recombinant or stably-transformed bacterium encoding one or...
Patent
1982-01-05
1983-08-23
Fagelson, Anna P.
Drug, bio-affecting and body treating compositions
Antigen, epitope, or other immunospecific immunoeffector
Recombinant or stably-transformed bacterium encoding one or...
424325, 424335, A61K 3114, A61K 31095
Patent
active
044003978
ABSTRACT:
Certain quaternary ammonium sulfites and bisulfites display anticoagulant and antithrombotic activity.
REFERENCES:
patent: 2367302 (1945-01-01), Moore
patent: 3836639 (1974-09-01), Teler
patent: 3906109 (1975-09-01), Roehm
Chao, Thrombos. Haemostas (Stuttg) vol. 35, 1976 pp. 717-736.
Shulman, Chem. Abs., vol. 47, 1953 p. 9386.
Gunnison, Fd. Cosmet. Toxicol. vol. 19, 1981 pp. 667-682.
Elias, Abstract of Thromb. Diath Haemorrh, vol. 18 (3-4), 1967 pp. 499-509.
Torda, Abs. of Anaesth. Intens. Care, 1, 293, (1973).
Bourbon, Abs. of J. Eur. Toxicol., vol. 4, No. 3 pp. 205-207 (1971).
Chem. Abs., 9th Coll. Index p. 37336CS & vol. 82, Ab No. 107247f (1975).
Kikugawa J. Pharm. Sci., vol. 61, 1972 pp. 1904-1907.
Rost, "Comparative Invst. of The Pharmacol. Effects of Organically Bonded Sulfurous Acids and of Neutral Sodium Sulfite" in Arb. A. D. Kaiserlichen Gesundheitsamte, vol. 21, 1904 p. 312.
Arias Alvarez Jose A.
Thompson Ralph B.
Fagelson Anna P.
T & R Chemicals, Inc.
LandOfFree
Antithrombotic treatment with quaternary ammonium sulfites and b does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Antithrombotic treatment with quaternary ammonium sulfites and b, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Antithrombotic treatment with quaternary ammonium sulfites and b will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1947229